154 related articles for article (PubMed ID: 22768290)
1. Single nucleotide polymorphism (SNP)-based loss of heterozygosity (LOH) testing by real time PCR in patients suspect of myeloproliferative disease.
Huijsmans CJ; Poodt J; Damen J; van der Linden JC; Savelkoul PH; Pruijt JF; Hilbink M; Hermans MH
PLoS One; 2012; 7(7):e38362. PubMed ID: 22768290
[TBL] [Abstract][Full Text] [Related]
2. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between TET2 Gene SNP rs3733609 C/T and JAK2V617F Allele Burden in Patients with Myeloproliferative Neoplasms].
Xiao X; Liu XL; Shen XH; Deng MY; Liu SF; Zhang GS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1574-1579. PubMed ID: 31607314
[TBL] [Abstract][Full Text] [Related]
4. Clinical and laboratory significance of defective P2Y(12) pathway function in patients with myeloproliferative neoplasms: a pilot study.
Chang H; Shih LY; Michelson AD; Dunn P; Frelinger AL; Wang PN; Kuo MC; Lin TL; Wu JH; Tang TC
Acta Haematol; 2013; 130(3):181-7. PubMed ID: 23751441
[TBL] [Abstract][Full Text] [Related]
5. Sensitive detection and quantification of the JAK2V617F allele by real-time PCR blocking wild-type amplification by using a peptide nucleic acid oligonucleotide.
Huijsmans CJ; Poodt J; Savelkoul PH; Hermans MH
J Mol Diagn; 2011 Sep; 13(5):558-64. PubMed ID: 21723417
[TBL] [Abstract][Full Text] [Related]
6. Loss of wild-type Jak2 allele enhances myeloid cell expansion and accelerates myelofibrosis in Jak2V617F knock-in mice.
Akada H; Akada S; Hutchison RE; Mohi G
Leukemia; 2014 Aug; 28(8):1627-35. PubMed ID: 24480985
[TBL] [Abstract][Full Text] [Related]
7. Quantitative competitive allele-specific TaqMan duplex PCR (qCAST-Duplex PCR) assay: a refined method for highly sensitive and specific detection of
Hsu CC; Huang CE; Wu YY; Chen YY; Lung J; Leu YW; Li CP; Tsou HY; Chuang WH; Lu CH; Chen CC
Haematologica; 2018 Oct; 103(10):e450-e454. PubMed ID: 29748437
[No Abstract] [Full Text] [Related]
8. [Detection of JAK2V617F mutation rate by real-time fluorescent quantitative PCR using allele specific primer and TaqMan-MGB probe for dual inhibiting amplification of wild type alleles].
Liang GW; Shao DH; He ML; Cao QY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1486-91. PubMed ID: 23257459
[TBL] [Abstract][Full Text] [Related]
9. Relationship between JAK2V617F mutation, allele burden and coagulation function in Ph-negative myeloproliferative neoplasms.
Hu L; Pu L; Ding Y; Li M; Cabanero M; Xie J; Zhou D; Yang D; Zhang C; Wang H; Zhai Z; Ru X; Li J; Xiong S
Hematology; 2017 Jul; 22(6):354-360. PubMed ID: 27976991
[TBL] [Abstract][Full Text] [Related]
10. A real-time polymerase chain reaction assay for rapid, sensitive, and specific quantification of the JAK2V617F mutation using a locked nucleic acid-modified oligonucleotide.
Denys B; El Housni H; Nollet F; Verhasselt B; Philippé J
J Mol Diagn; 2010 Jul; 12(4):512-9. PubMed ID: 20431031
[TBL] [Abstract][Full Text] [Related]
11. Thromboses and hemorrhages are common in MPN patients with high JAK2V617F allele burden.
Bertozzi I; Bogoni G; Biagetti G; Duner E; Lombardi AM; Fabris F; Randi ML
Ann Hematol; 2017 Aug; 96(8):1297-1302. PubMed ID: 28585070
[TBL] [Abstract][Full Text] [Related]
12. Thrombosis in myeloproliferative neoplasms with JAK2V617F mutation.
Sun T; Zhang L
Clin Appl Thromb Hemost; 2013; 19(4):374-81. PubMed ID: 22826442
[TBL] [Abstract][Full Text] [Related]
13. [Progress of study on JAK2V617F mutation in myeloproliferative neoplasm].
Chen YX; Li Y; Zhang LY; Liu B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1329-33. PubMed ID: 22040998
[TBL] [Abstract][Full Text] [Related]
14. Telomere length is severely and similarly reduced in JAK2V617F-positive and -negative myeloproliferative neoplasms.
Bernard L; Belisle C; Mollica L; Provost S; Roy DC; Gilliland DG; Levine RL; Busque L
Leukemia; 2009 Feb; 23(2):287-91. PubMed ID: 19005480
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Risk for Specific Somatic Myeloproliferative Neoplastic Mutations in Patients with Stroke.
Chen CC; Hsu CC; Huang CE; Chen YY; Lung J; Ho HY; Li CP; Lee JD
Curr Neurovasc Res; 2017; 14(3):222-231. PubMed ID: 28625126
[TBL] [Abstract][Full Text] [Related]
16. A novel, highly sensitive and rapid allele-specific loop-mediated amplification assay for the detection of the JAK2V617F mutation in chronic myeloproliferative neoplasms.
Minnucci G; Amicarelli G; Salmoiraghi S; Spinelli O; Guinea Montalvo ML; Giussani U; Adlerstein D; Rambaldi A
Haematologica; 2012 Sep; 97(9):1394-400. PubMed ID: 22315499
[TBL] [Abstract][Full Text] [Related]
17. Melting curve analysis after T allele enrichment (MelcaTle) as a highly sensitive and reliable method for detecting the JAK2V617F mutation.
Morishita S; Takahashi K; Araki M; Hironaka Y; Sunami Y; Edahiro Y; Tsutsui M; Ohsaka A; Tsuneda S; Komatsu N
PLoS One; 2015; 10(3):e0122003. PubMed ID: 25794279
[TBL] [Abstract][Full Text] [Related]
18. The effects of mutational profiles on phenotypic presentation of myeloproliferative neoplasm subtypes in Bosnia: 18 year follow-up.
Kurtovic-Kozaric A; Islamagic E; Komic H; Bilalovic N; Eminovic I; Burekovic A; Uzunovic A; Kurtovic S
Bosn J Basic Med Sci; 2020 May; 20(2):236-247. PubMed ID: 31668145
[TBL] [Abstract][Full Text] [Related]
19. Loss of pleckstrin-2 reverts lethality and vascular occlusions in JAK2V617F-positive myeloproliferative neoplasms.
Zhao B; Mei Y; Cao L; Zhang J; Sumagin R; Yang J; Gao J; Schipma MJ; Wang Y; Thorsheim C; Zhao L; Stalker T; Stein B; Wen QJ; Crispino JD; Abrams CS; Ji P
J Clin Invest; 2018 Jan; 128(1):125-140. PubMed ID: 29202466
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumors using the MassEXTEND assay: single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase receptor type J in familial colorectal cancer.
van Puijenbroek M; Dierssen JW; Stanssens P; van Eijk R; Cleton-Jansen AM; van Wezel T; Morreau H
J Mol Diagn; 2005 Nov; 7(5):623-30. PubMed ID: 16258161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
